Global Superficial Bladder Cancer Drugs Market Research Report 2016

December 2016 | 105 pages | ID: G1BC7F61EC3EN
QYResearch

Abstracts

Notes:

Production, means the output of Superficial Bladder Cancer Drugs

Revenue, means the sales value of Superficial Bladder Cancer Drugs

This report studies Superficial Bladder Cancer Drugs in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering

• Altor BioScience Corporation
• APIM Therapeutics AS
• Bavarian Nordic A/S
• Cold Genesys, Inc.
• Spectrum Pharmaceuticals, Inc.
• Telesta Therapeutics Inc.
• UroGen Pharmaceuticals, Ltd.
• Viventia Bio Inc.
• endo pharmaceutical
• SANOFI

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Superficial Bladder Cancer Drugs in these regions, from 2011 to 2021 (forecast), like

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by application, this report focuses on consumption, market share and growth rate of Superficial Bladder Cancer Drugs in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Global Superficial Bladder Cancer Drugs Market Research Report 2016

1 SUPERFICIAL BLADDER CANCER DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Superficial Bladder Cancer Drugs
1.2 Superficial Bladder Cancer Drugs Segment by Type
  1.2.1 Global Production Market Share of Superficial Bladder Cancer Drugs by Type in 2015
  1.2.2 Type I
  1.2.3 Type II
  1.2.4 Type III
1.3 Superficial Bladder Cancer Drugs Segment by Application
  1.3.1 Superficial Bladder Cancer Drugs Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Superficial Bladder Cancer Drugs Market by Region
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 Europe Status and Prospect (2011-2021)
  1.4.3 China Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Superficial Bladder Cancer Drugs (2011-2021)

2 GLOBAL SUPERFICIAL BLADDER CANCER DRUGS MARKET COMPETITION BY MANUFACTURERS

2.1 Global Superficial Bladder Cancer Drugs Production and Share by Manufacturers (2015 and 2016)
2.2 Global Superficial Bladder Cancer Drugs Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Superficial Bladder Cancer Drugs Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Superficial Bladder Cancer Drugs Manufacturing Base Distribution, Sales Area and Product Type
2.5 Superficial Bladder Cancer Drugs Market Competitive Situation and Trends
  2.5.1 Superficial Bladder Cancer Drugs Market Concentration Rate
  2.5.2 Superficial Bladder Cancer Drugs Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL SUPERFICIAL BLADDER CANCER DRUGS PRODUCTION, REVENUE (VALUE) BY REGION (2011-2016)

3.1 Global Superficial Bladder Cancer Drugs Production and Market Share by Region (2011-2016)
3.2 Global Superficial Bladder Cancer Drugs Revenue (Value) and Market Share by Region (2011-2016)
3.3 Global Superficial Bladder Cancer Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.4 North America Superficial Bladder Cancer Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.5 Europe Superficial Bladder Cancer Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.6 China Superficial Bladder Cancer Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.7 Japan Superficial Bladder Cancer Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Southeast Asia Superficial Bladder Cancer Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.9 India Superficial Bladder Cancer Drugs Production, Revenue, Price and Gross Margin (2011-2016)

4 GLOBAL SUPERFICIAL BLADDER CANCER DRUGS SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2011-2016)

4.1 Global Superficial Bladder Cancer Drugs Consumption by Regions (2011-2016)
4.2 North America Superficial Bladder Cancer Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Superficial Bladder Cancer Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Superficial Bladder Cancer Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Superficial Bladder Cancer Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Superficial Bladder Cancer Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Superficial Bladder Cancer Drugs Production, Consumption, Export, Import by Regions (2011-2016)

5 GLOBAL SUPERFICIAL BLADDER CANCER DRUGS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Superficial Bladder Cancer Drugs Production and Market Share by Type (2011-2016)
5.2 Global Superficial Bladder Cancer Drugs Revenue and Market Share by Type (2011-2016)
5.3 Global Superficial Bladder Cancer Drugs Price by Type (2011-2016)
5.4 Global Superficial Bladder Cancer Drugs Production Growth by Type (2011-2016)

6 GLOBAL SUPERFICIAL BLADDER CANCER DRUGS MARKET ANALYSIS BY APPLICATION

6.1 Global Superficial Bladder Cancer Drugs Consumption and Market Share by Application (2011-2016)
6.2 Global Superficial Bladder Cancer Drugs Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL SUPERFICIAL BLADDER CANCER DRUGS MANUFACTURERS PROFILES/ANALYSIS

7.1 Altor BioScience Corporation
  7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.1.2 Superficial Bladder Cancer Drugs Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Altor BioScience Corporation Superficial Bladder Cancer Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.1.4 Main Business/Business Overview
7.2 APIM Therapeutics AS
  7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.2.2 Superficial Bladder Cancer Drugs Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 APIM Therapeutics AS Superficial Bladder Cancer Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.2.4 Main Business/Business Overview
7.3 Bavarian Nordic A/S
  7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.3.2 Superficial Bladder Cancer Drugs Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 Bavarian Nordic A/S Superficial Bladder Cancer Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.3.4 Main Business/Business Overview
7.4 Cold Genesys, Inc.
  7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.4.2 Superficial Bladder Cancer Drugs Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Cold Genesys, Inc. Superficial Bladder Cancer Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.4.4 Main Business/Business Overview
7.5 Spectrum Pharmaceuticals, Inc.
  7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.5.2 Superficial Bladder Cancer Drugs Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Spectrum Pharmaceuticals, Inc. Superficial Bladder Cancer Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.5.4 Main Business/Business Overview
7.6 Telesta Therapeutics Inc.
  7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.6.2 Superficial Bladder Cancer Drugs Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Telesta Therapeutics Inc. Superficial Bladder Cancer Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.6.4 Main Business/Business Overview
7.7 UroGen Pharmaceuticals, Ltd.
  7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.7.2 Superficial Bladder Cancer Drugs Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 UroGen Pharmaceuticals, Ltd. Superficial Bladder Cancer Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.7.4 Main Business/Business Overview
7.8 Viventia Bio Inc.
  7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.8.2 Superficial Bladder Cancer Drugs Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 Viventia Bio Inc. Superficial Bladder Cancer Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.8.4 Main Business/Business Overview
7.9 endo pharmaceutical
  7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.9.2 Superficial Bladder Cancer Drugs Product Type, Application and Specification
    7.9.2.1 Type I
    7.9.2.2 Type II
  7.9.3 endo pharmaceutical Superficial Bladder Cancer Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.9.4 Main Business/Business Overview
7.10 SANOFI
  7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.10.2 Superficial Bladder Cancer Drugs Product Type, Application and Specification
    7.10.2.1 Type I
    7.10.2.2 Type II
  7.10.3 SANOFI Superficial Bladder Cancer Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.10.4 Main Business/Business Overview

8 SUPERFICIAL BLADDER CANCER DRUGS MANUFACTURING COST ANALYSIS

8.1 Superficial Bladder Cancer Drugs Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Superficial Bladder Cancer Drugs

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Superficial Bladder Cancer Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Superficial Bladder Cancer Drugs Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL SUPERFICIAL BLADDER CANCER DRUGS MARKET FORECAST (2016-2021)

12.1 Global Superficial Bladder Cancer Drugs Production, Revenue Forecast (2016-2021)
12.2 Global Superficial Bladder Cancer Drugs Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Superficial Bladder Cancer Drugs Production Forecast by Type (2016-2021)
12.4 Global Superficial Bladder Cancer Drugs Consumption Forecast by Application (2016-2021)
12.5 Superficial Bladder Cancer Drugs Price Forecast (2016-2021)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Disclosure Section
Research Methodology
Data Source
China Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Superficial Bladder Cancer Drugs
Figure Global Production Market Share of Superficial Bladder Cancer Drugs by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Superficial Bladder Cancer Drugs Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure North America Superficial Bladder Cancer Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Superficial Bladder Cancer Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Superficial Bladder Cancer Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Superficial Bladder Cancer Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Superficial Bladder Cancer Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Superficial Bladder Cancer Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Superficial Bladder Cancer Drugs Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Superficial Bladder Cancer Drugs Production of Key Manufacturers (2015 and 2016)
Table Global Superficial Bladder Cancer Drugs Production Share by Manufacturers (2015 and 2016)
Figure 2015 Superficial Bladder Cancer Drugs Production Share by Manufacturers
Figure 2016 Superficial Bladder Cancer Drugs Production Share by Manufacturers
Table Global Superficial Bladder Cancer Drugs Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Superficial Bladder Cancer Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Superficial Bladder Cancer Drugs Revenue Share by Manufacturers
Table 2016 Global Superficial Bladder Cancer Drugs Revenue Share by Manufacturers
Table Global Market Superficial Bladder Cancer Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Superficial Bladder Cancer Drugs Average Price of Key Manufacturers in 2015
Table Manufacturers Superficial Bladder Cancer Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Superficial Bladder Cancer Drugs Product Type
Figure Superficial Bladder Cancer Drugs Market Share of Top 3 Manufacturers
Figure Superficial Bladder Cancer Drugs Market Share of Top 5 Manufacturers
Table Global Superficial Bladder Cancer Drugs Production by Regions (2011-2016)
Figure Global Superficial Bladder Cancer Drugs Production and Market Share by Regions (2011-2016)
Figure Global Superficial Bladder Cancer Drugs Production Market Share by Regions (2011-2016)
Figure 2015 Global Superficial Bladder Cancer Drugs Production Market Share by Regions
Table Global Superficial Bladder Cancer Drugs Revenue by Regions (2011-2016)
Table Global Superficial Bladder Cancer Drugs Revenue Market Share by Regions (2011-2016)
Table 2015 Global Superficial Bladder Cancer Drugs Revenue Market Share by Regions
Table Global Superficial Bladder Cancer Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Superficial Bladder Cancer Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Superficial Bladder Cancer Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table China Superficial Bladder Cancer Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Superficial Bladder Cancer Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Superficial Bladder Cancer Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table India Superficial Bladder Cancer Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Superficial Bladder Cancer Drugs Consumption Market by Regions (2011-2016)
Table Global Superficial Bladder Cancer Drugs Consumption Market Share by Regions (2011-2016)
Figure Global Superficial Bladder Cancer Drugs Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Superficial Bladder Cancer Drugs Consumption Market Share by Regions
Table North America Superficial Bladder Cancer Drugs Production, Consumption, Import & Export (2011-2016)
Table Europe Superficial Bladder Cancer Drugs Production, Consumption, Import & Export (2011-2016)
Table China Superficial Bladder Cancer Drugs Production, Consumption, Import & Export (2011-2016)
Table Japan Superficial Bladder Cancer Drugs Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Superficial Bladder Cancer Drugs Production, Consumption, Import & Export (2011-2016)
Table India Superficial Bladder Cancer Drugs Production, Consumption, Import & Export (2011-2016)
Table Global Superficial Bladder Cancer Drugs Production by Type (2011-2016)
Table Global Superficial Bladder Cancer Drugs Production Share by Type (2011-2016)
Figure Production Market Share of Superficial Bladder Cancer Drugs by Type (2011-2016)
Figure 2015 Production Market Share of Superficial Bladder Cancer Drugs by Type
Table Global Superficial Bladder Cancer Drugs Revenue by Type (2011-2016)
Table Global Superficial Bladder Cancer Drugs Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Superficial Bladder Cancer Drugs by Type (2011-2016)
Figure 2015 Revenue Market Share of Superficial Bladder Cancer Drugs by Type
Table Global Superficial Bladder Cancer Drugs Price by Type (2011-2016)
Figure Global Superficial Bladder Cancer Drugs Production Growth by Type (2011-2016)
Table Global Superficial Bladder Cancer Drugs Consumption by Application (2011-2016)
Table Global Superficial Bladder Cancer Drugs Consumption Market Share by Application (2011-2016)
Figure Global Superficial Bladder Cancer Drugs Consumption Market Share by Application in 2015
Table Global Superficial Bladder Cancer Drugs Consumption Growth Rate by Application (2011-2016)
Figure Global Superficial Bladder Cancer Drugs Consumption Growth Rate by Application (2011-2016)
Table Altor BioScience Corporation Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Altor BioScience Corporation Superficial Bladder Cancer Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Altor BioScience Corporation Superficial Bladder Cancer Drugs Market Share (2011-2016)
Table APIM Therapeutics AS Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table APIM Therapeutics AS Superficial Bladder Cancer Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure APIM Therapeutics AS Superficial Bladder Cancer Drugs Market Share (2011-2016)
Table Bavarian Nordic A/S Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bavarian Nordic A/S Superficial Bladder Cancer Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Bavarian Nordic A/S Superficial Bladder Cancer Drugs Market Share (2011-2016)
Table Cold Genesys, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Cold Genesys, Inc. Superficial Bladder Cancer Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Cold Genesys, Inc. Superficial Bladder Cancer Drugs Market Share (2011-2016)
Table Spectrum Pharmaceuticals, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Spectrum Pharmaceuticals, Inc. Superficial Bladder Cancer Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Spectrum Pharmaceuticals, Inc. Superficial Bladder Cancer Drugs Market Share (2011-2016)
Table Telesta Therapeutics Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Telesta Therapeutics Inc. Superficial Bladder Cancer Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Telesta Therapeutics Inc. Superficial Bladder Cancer Drugs Market Share (2011-2016)
Table UroGen Pharmaceuticals, Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table UroGen Pharmaceuticals, Ltd. Superficial Bladder Cancer Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure UroGen Pharmaceuticals, Ltd. Superficial Bladder Cancer Drugs Market Share (2011-2016)
Table Viventia Bio Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Viventia Bio Inc. Superficial Bladder Cancer Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Viventia Bio Inc. Superficial Bladder Cancer Drugs Market Share (2011-2016)
Table endo pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table endo pharmaceutical Superficial Bladder Cancer Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure endo pharmaceutical Superficial Bladder Cancer Drugs Market Share (2011-2016)
Table SANOFI Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table SANOFI Superficial Bladder Cancer Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure SANOFI Superficial Bladder Cancer Drugs Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Superficial Bladder Cancer Drugs
Figure Manufacturing Process Analysis of Superficial Bladder Cancer Drugs
Figure Superficial Bladder Cancer Drugs Industrial Chain Analysis
Table Raw Materials Sources of Superficial Bladder Cancer Drugs Major Manufacturers in 2015
Table Major Buyers of Superficial Bladder Cancer Drugs
Table Distributors/Traders List
Figure Global Superficial Bladder Cancer Drugs Production and Growth Rate Forecast (2016-2021)
Figure Global Superficial Bladder Cancer Drugs Revenue and Growth Rate Forecast (2016-2021)
Table Global Superficial Bladder Cancer Drugs Production Forecast by Regions (2016-2021)
Table Global Superficial Bladder Cancer Drugs Consumption Forecast by Regions (2016-2021)
Table Global Superficial Bladder Cancer Drugs Production Forecast by Type (2016-2021)
Table Global Superficial Bladder Cancer Drugs Consumption Forecast by Application (2016-2021)